We are live on ! Find out more
PA

PharVision Advisers Portfolio holdings

AUM $9.86M
1-Year Est. Return 9.93%
This Fund
S&P 500
This Quarter Est. Return
+0.93%
1 Year Est. Return
+9.93%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$198M
AUM Growth
+$19.8M
Cap. Flow
+$23.3M
Cap. Flow %
11.78%
Top 10 Hldgs %
3.45%
Holding
1,063
New
409
Increased
141
Reduced
117
Closed
396

Top Buys

Rank Stock Value
1
DK icon
Delek US
DK
+$871K
2
AVGO icon
Broadcom
AVGO
+$691K
3
A icon
Agilent Technologies
A
+$650K
4
TLS icon
Telos
TLS
+$640K
5
PGY icon
Pagaya Technologies
PGY
+$627K

Top Sells

Rank Stock Value
1
ARRY icon
Array Technologies
ARRY
+$730K
2
VRT icon
Vertiv
VRT
+$639K
3
ZVRA icon
Zevra Therapeutics
ZVRA
+$635K
4
BOW
Bowhead Specialty Holdings
BOW
+$608K
5
RIGL icon
Rigel Pharmaceuticals
RIGL
+$581K

Sector Composition

Rank Sector Weight
1 Technology 18.19%
2 Industrials 15.13%
3 Financials 12.4%
4 Consumer Discretionary 11.79%
5 Healthcare 11.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SFM icon
226
Sprouts Farmers Market
SFM
$7.32B
$330K 0.17%
4,148
-2,510
-38% -$225K
CAT icon
227
Caterpillar
CAT
$385B
$328K 0.17%
+572
New +$318K
ORGO icon
228
Organogenesis Holdings
ORGO
$332M
$327K 0.17%
63,189
+26,488
+72% +$128K
ISSC icon
229
Innovative Solutions & Support
ISSC
$337M
$327K 0.17%
+17,274
New +$197K
AMP icon
230
Ameriprise Financial
AMP
$48.3B
$326K 0.17%
665
+211
+46% +$100K
TCPC icon
231
BlackRock TCP Capital
TCPC
$273M
$324K 0.16%
+59,177
New +$341K
VEEV icon
232
Veeva Systems
VEEV
$32.7B
$323K 0.16%
1,447
+142
+11% +$37.7K
CIO
233
DELISTED
City Office REIT
CIO
$323K 0.16%
+46,164
New +$320K
FIVN icon
234
FIVE9
FIVN
$2.08B
$322K 0.16%
16,073
+7,699
+92% +$163K
AIP icon
235
Arteris
AIP
$1.33B
$320K 0.16%
+20,655
New +$299K
CAKE icon
236
Cheesecake Factory
CAKE
$4.4B
$319K 0.16%
6,319
-24
-0.4% -$1.2K
SEM
237
DELISTED
Select Medical
SEM
$319K 0.16%
+21,451
New +$303K
KRC icon
238
Kilroy Realty
KRC
$4.45B
$318K 0.16%
+8,521
New +$348K
NRDS icon
239
NerdWallet
NRDS
$629M
$318K 0.16%
+23,480
New +$307K
CENTA icon
240
Central Garden & Pet Co Class A
CENTA
$2.46B
$317K 0.16%
+10,858
New +$314K
MSI icon
241
Motorola Solutions
MSI
$73.2B
$316K 0.16%
+825
New +$332K
EYE icon
242
National Vision
EYE
$1.73B
$315K 0.16%
12,216
+1,975
+19% +$53.1K
ESE icon
243
ESCO Technologies
ESE
$8.2B
$314K 0.16%
+1,608
New +$339K
MNTN
244
MNTN Inc
MNTN
$708M
$314K 0.16%
+26,288
New +$379K
PI icon
245
Impinj
PI
$4.04B
$314K 0.16%
+1,803
New +$321K
IDXX icon
246
Idexx Laboratories
IDXX
$44.8B
$313K 0.16%
+463
New +$315K
MPC icon
247
Marathon Petroleum
MPC
$90.6B
$313K 0.16%
+1,924
New +$360K
SNAP icon
248
Snap
SNAP
$7.99B
$313K 0.16%
+38,762
New +$307K
HI
249
DELISTED
Hillenbrand
HI
$313K 0.16%
+9,859
New +$304K
CHH icon
250
Choice Hotels
CHH
$5.23B
$313K 0.16%
3,282
+1,141
+53% +$109K
8 9
10
11 12

Similar funds

BS
BCI Securities Miami, Florida $10.1M AUM
RG
Raine Group New York $10.5M AUM 23.14% 1-Year Est. Return
MP
MVM Partners Boston, Massachusetts $10.8M AUM 61.97% 1-Year Est. Return
CCM
Crabel Capital Management Los Angeles, California $10.8M AUM 3.34% 1-Year Est. Return
DFA
Davies Financial Advisors Murrieta, California $10.9M AUM 21.57% 1-Year Est. Return
CCP
Caden Capital Partners Santa Monica, California $8.12M AUM 16.97% 1-Year Est. Return
FRT
FTX Recovery Trust League City, Texas $11.8M AUM
VH
Vitol Holding Rotterdam, Netherlands $11.9M AUM 27.28% 1-Year Est. Return

PharVision Advisers's Q4 2025 Portfolio in Review

As of Q4 2025, PharVision Advisers held 1,063 positions worth $198M, up 11% from $178M the previous quarter. Its ten largest holdings account for 3.5% of the portfolio.

PharVision Advisers deployed $23.3M of net new capital in Q4 2025, opening 409 new positions and adding to 141 existing holdings. Its largest new stake was Delek US: 24,407 shares worth $724K.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was Wayfair, an estimated $510K trimmed.

  • PharVision Advisers's largest Q4 2025 buy was Delek US: 24,407 shares worth $724K.
  • PharVision Advisers added most to NIO in Q4 2025, an estimated $557K increase.
  • PharVision Advisers's biggest Q4 2025 reduction was Wayfair, cutting an estimated $510K.
  • PharVision Advisers fully exited Array Technologies in Q4 2025, selling an estimated $730K.
  • PharVision Advisers's ten largest holdings make up 3.5% of its $198M portfolio in Q4 2025.
  • PharVision Advisers opened 409 new positions and closed 396 in Q4 2025.
  • PharVision Advisers's portfolio value rose 11% quarter-over-quarter to $198M.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.